Select for export EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE Details DOI 10.1016/j.jval.2026.03.422 Copy citation Copy BibTeX Value in Health 2026-05-31 Matthew Sidovar, Shane J. O’Connor, Lucinda Orsini OpenAlex Published psilocybin Review ArticleToxicity Review Article Mental health care More
Select for export EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION Details DOI 10.1016/j.jval.2026.03.635 Copy citation Copy BibTeX Value in Health 2026-05-31 Yosr Ziadi, Taehwan Park OpenAlex Published psilocybin DepressionPersonality ChangeTreatment-Resistant Depression Other Medicine More